• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

I Dont Want To Get Rid Of My Psoriasis
HealthValeant Stock Was Having a Pretty Good 2018—Until Today
By Sy MukherjeeJune 18, 2018
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
HealthValeant Is Changing Names—And Its Stock Is Soaring After a Much-Needed FDA Approval
By Sy MukherjeeMay 8, 2018
Female Sex Pill
HealthShould ‘Female Viagra’ Have Ever Been Approved?
By Sy MukherjeeNovember 7, 2017
Cosmopolitan: Let's Talk About It Event
FinanceValeant Is Paying to Get Rid of Its $1 Billion ‘Female Viagra’ Acquisition
By Jen WiecznerNovember 6, 2017
Valeant CEO Joseph Papa. The stock soared Tuesday after a rosy forecast.
FinanceValeant Stock Is Soaring After the Drugmaker Boosts Its Outlook
By ReutersMay 9, 2017
Perrigo Co. Chief Executive Officer Joe Papa Interview
HealthWhy Valeant Stock Just Plunged Into the Single Digits
By Sy MukherjeeApril 5, 2017
Bill Ackman herbalife
FinanceBill Ackman Finally Apologizes for His ‘Huge Mistake’ With Valeant
By Lucinda ShenMarch 29, 2017
Perrigo Co. Chief Executive Officer Joe Papa Interview
FinanceValeant’s New CEO Joe Papa Has a $17 Billion Ultimatum
By Jen WiecznerMarch 29, 2017
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant’s Former CEO Is Suing the Company for 3 Million Allegedly Unpaid Shares
By ReutersMarch 27, 2017
Bill Ackman herbalife
FinanceBill Ackman Lost $7.7 Million Per Day on Valeant Stock
By Jen WiecznerMarch 15, 2017
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceValeant’s Debt Refinance Will Go On Without Bill Ackman
By ReutersMarch 14, 2017
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
FinanceWhy Ackman’s Exit May Not Be the End of Valeant’s Stock Plunge
By Jeff BukhariMarch 14, 2017
Key Speakers At The New York Times DealBook Conference
FinanceValeant Stock Is Bringing Bill Ackman’s Hedge Fund Back From the Dead
By Jen WiecznerFebruary 17, 2017
Perrigo Co. Chief Executive Officer Joe Papa Interview
FinanceValeant Just Made a Killing on a Series of Drug Deals
By Jen WiecznerJanuary 10, 2017
Valeant Pharmaceuticals International Inc's new chief executive Joseph Papa answers questions from shareholders during their annual general meeting in Laval
FinanceHere’s What Wall Street Has to Say About Valeant’s L’Oreal and Sanpower Deals
By Lucinda ShenJanuary 10, 2017
1
  • 1
  • 2
  • 3
  • 4
  • 5
...12
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that first step’An image of a popular article
By Sydney LakeFebruary 25, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.